IN RE: GENERIC PHARMACEUTICALS PRICING ANTITRUST LITIGATION
Case Number:
2:16-md-02724
Court:
Nature of Suit:
Multi Party Litigation:
Class Action, Multi-district Litigation
Judge:
Firms
- Skadden Arps
- Hach Rose Schirripa
- Sarraf Gentile
- Proskauer Rose
- Gustafson Gluek
- Feldman Shepherd
- Tarter Krinsky
- Cozen O'Connor
- Hagens Berman
- Saltz Mongeluzzi
- Fiddler Gonzalez
- Wilson Sonsini
- McCune Law
- Pashman Stein
- Anselmi & Carvelli
- Ahern and Associates
- DLA Piper
- Cotsirilos Poulos
- Wexler Boley
- Kelley Drye
- Blank Rome
- Spiro Harrison
- Harkins Cunningham
- Kaplan Fox
- Arnold & Porter
- Armstrong Teasdale
- Levin Sedran
- Dilworth Paxson
- Gross & Belsky
- McDermott Will & Schulte
- Earp Cohn
- Edelson Lechtzin
- Freedman Boyd
- Steyer Lowenthal
- Faruqi & Faruqi
- Cera LLP
- Garwin Gerstein
- Girard Sharp
- Sills Cummis
- Krantz & Berman
- Tostrud Law Group
- Grabar Law
- Rosenn Jenkins
- Barrack Rodos
- Hecht Partners
- Rosca Scarlato
- DeCotiis FitzPatrick
- Berry Law LLC
- NastLaw
- Latham & Watkins
- Pendley Baudin
- Zwerling Schachter
- Rule Garza
- Joseph Saveri Law Firm
- Competition Law Partners
- Axinn
- King & Spalding
- Patterson Belknap
- Ballard Spahr
- Pogust Goodhead
- Winston Taylor
- Lockridge Grindal
- Bryan Cave Leighton Paisner
- Kaufman Dolowich
- Wiggin & Dana
- Boies Schiller
- Buchanan Ingersoll
- Stradley Ronon
- Foley & Lardner
- Barrett Law Group
- Bartlit Beck
- Saiber LLC
- Polsinelli PC
- Linklaters LLP
- Carella Byrne
- McConnell Valdes
- Lewis Brisbois
- Safirstein Law
- Bourelly George
- Reed Smith
- Schertler Onorato
- Paul Weiss
- Zelle LLP
- Seeger Weiss
- Neufeld Scheck
- Spector Roseman
- Goldman Scarlato
- Norton Rose
- Baker Botts
- Zuckerman Spaeder
- Welsh & Recker
- Kang Haggerty
- Shapiro Arato
- Hausfeld LLP
- Royer Cooper
- Roberts Law Firm US
- Cleary Gottlieb
- K&L Gates
- Vinson & Elkins
- Berger Montague
- Hangley Aronchick
- Stueve Siegel
- O'Melveny & Myers
- Obermayer Rebmann
- Bailey & Glasser
- Venable LLP
- Lyden Chappell
- Morrison & Foerster
- Stevens & Lee
- Andrus Anderson
- Hogan Lovells
- Thomas Kadian LLC
- White and Williams
- Bonsignore Trial Lawyers
- Simpson Thacher & Bartlett
- Napoli Shkolnik
- Robbins Geller
- Cohen Milstein
- Kohn Swift
- Wisner Baum
- George Feldman
- Haynes Boone
- Williams & Connolly
- Crowell & Moring
- Bailey Duquette
- McCracken Stemerman
- Calcaterra Pollack
- Miller Barondess
- Shinder Cantor
- Debevoise & Plimpton
- Tycko & Zavareei
- Duane Morris
- Hughes Hubbard
- Schneider Wallace
- Scott&Scott
- Lieff Cabraser
- Francis Mailman
- Morgan Lewis
- Nussbaum Law Group
- Fenwick & West
- WilmerHale
- Greenberg Traurig
- Larson King
- Faegre Drinker
- Gordon Rees
- DiCello Levitt
- Lowenstein Sandler
- Cole Schotz
- Weil Gotshal
- Butler Reichline
- Dugan Law Firm
- Langer Grogan
- Bowditch & Dewey
- Law Offices of Francis O. Scarpulla
- Walsh Pizzi
- Petrillo Klein
- Heins Mills
- Kasowitz LLP
- Manatt Phelps
- Kralowec Law
- Furth Salem
- Motley Rice
- Lundy Beldecos
- Goodwin Procter
- Segal McCambridge
- Pullman & Comley
- Barnes & Thornburg
- Steptoe LLP
- Gruenstein Law
- Paul Hastings
- Alston & Bird
- Baker & Hostetler
- Troutman
- Davis Wright Tremaine
- Fox Rothschild
- Cuneo Gilbert
- Yarborough Law Firm
- Freshfields
- Pierce Bainbridge
- Wolf Haldenstein
- Cotchett Pitre
- Brandon J. Broderick LLC
- Kirkland & Ellis
- White & Case
- Burns Charest
- Gibson Dunn
- Lowey Dannenberg
- Steven Williams Law
- Taus Cebulash
- Bingham McCutchen
- Dechert LLP
- Seward & Kissel
- Miller & Chevalier
- Lite DePalma
- Berman Tabacco
- Radice Law Firm
- Whatley Kallas
- O’Neill & Borges
- Sperling Kenny
- Clark Hill
- Miller Shah
- Zimmerman Reed
- Susman Godfrey
- Glancy Prongay
- Constantine Cannon
- Harris St. Laurent
- Carter Ledyard
- Shipman & Goodwin
- Fine Kaplan
- Grant & Eisenhofer
- Labaton Keller
- Haug Partners
- Saveri & Saveri
Companies
- Molina Healthcare Inc.
- Lupin Ltd.
- J.M. Smith Corp.
- Hikma Pharmaceuticals PLC
- Emcure Pharmaceuticals Ltd.
- Perrigo Co. PLC
- Fougera Pharmaceuticals Inc.
- The Cigna Group
- Lannett Company, Inc
- McKesson Corp.
- Ascend Laboratories LLC
- PAR Inc.
- Hi-Tech Pharmacal Co., Inc.
- Aetna Inc.
- MSP Recovery
- Impax Laboratories, Inc.
- Dr. Reddy's Laboratories Ltd.
- Bausch Health Cos. Inc.
- Blue Cross Blue Shield Association
- Endo International PLC
- Sandoz International GmbH
- Aurobindo Pharma Ltd.
- Florida Blue
- Southwest Airlines Co.
- Amneal Pharmaceuticals Inc.
- Sun Pharmaceutical Industries Ltd.
- Albertsons Cos. Inc.
- Taro Pharmaceutical Industries Ltd.
- Red Oak Sourcing LLC
- Glenmark Pharmaceuticals Ltd.
- Humana Inc.
- Cardinal Health Inc.
- The Harvard Drug Group LLC
- Par Pharmaceutical Cos. Inc.
- Viatris Inc.
- Health Care Service Corp.
- United Food & Commercial Workers International Union
- Alvogen Group Inc.
- West-Ward Pharmaceutical Corp.
- Cadila Pharmaceuticals Ltd.
- Akorn Inc.
- Bi-Lo
- Avet Pharmaceuticals Inc.
- Allergan PLC
- Cencora Inc.
- Camber Pharmaceuticals Inc.
- Walmart Inc.
- Zydus Pharmaceuticals Inc.
- International Union Of Operating Engineers
- Walgreens Boots Alliance Inc.
- Centene Corp.
- G&W Laboratories Inc.
- The Kroger Co.
- Upsher-Smith Laboratories Inc.
- Rite Aid Corp.
- Winn-Dixie Stores, Inc.
- Wockhardt Ltd.
- Wockhardt USA LLC
- Pfizer Inc.
- Jubilant Cadista
- Novartis AG
- Teva Pharmaceutical Industries Ltd.
Government Agencies
Sectors & Industries:
-
February 01, 2024
State-Led Generic Drug Cases Removed From MDL
The Judicial Panel on Multidistrict Litigation has sent a trio of cases from state-level enforcers back to federal court in Connecticut, separating them from the sprawling MDL centralized in Pennsylvania over claims of price fixing in the generic drug industry.
-
January 23, 2024
3 Generic-Drug Cos. Reach Settlements In Price-Fixing MDL
Generic-drug makers Apotex Corp., Heritage Pharmaceuticals Ltd. and Breckenridge Pharmaceutical Inc. have each agreed to shell out a combined $45 million to settle allegations they colluded to fix the prices of many medications, according to a trio of motions filed Tuesday in multidistrict litigation in Pennsylvania federal court.
-
January 17, 2024
Generic-Drug Cos. Say States Are Mum In MDL Discovery
Generic-drug makers steeped in antitrust multidistrict litigation are asking for an order enforcing a months-old deadline for documents that most states have ignored, according to a memorandum filed in Pennsylvania federal court.
-
December 07, 2023
Generics Price-Fixing Cases Should Stay In MDL, Judge Says
The Pennsylvania federal judge overseeing sprawling multidistrict litigation against generic-drug makers on Thursday told the U.S. Judicial Panel on Multidistrict Litigation that she does not recommend transferring state enforcer actions out of the MDL yet, saying there's more the court can do to get the cases ready for trial or to tee up settlement talks.
-
November 02, 2023
States Want Generic Drug Price-Fixing Claims Back In Conn.
State enforcers accusing several generic drugmakers of price-fixing asked the Judicial Panel on Multidistrict Litigation to move their case back to Connecticut federal court, saying legislation signed by President Joe Biden last year spares state enforcers from the MDL process.
-
October 04, 2023
States Back Off Bid To Block Sandoz Spinoff In Antitrust Case
Novartis AG completed the planned spinoff of its Sandoz unit on Wednesday, after state enforcers and others withdrew their bid to block the move over concerns about recovering alleged overcharges from a sprawling conspiracy to fix generic drug prices.
-
September 29, 2023
States Ask To Block Sandoz Spinoff Over Price-Fixing Claims
State enforcers and others have asked a Pennsylvania federal court to halt Novartis AG's planned spinoff of its Sandoz unit, saying the move could stop them from recovering overcharges from the company for a sprawling conspiracy to fix generic drug prices.
-
August 17, 2023
DOJ Wants Equal Access To Docs in Ex-Exec's Criminal Case
The U.S. Department of Justice has urged a Pennsylvania federal judge to deny a former Taro Pharmaceutical executive's bid to use material from multidistrict litigation over alleged generic drug price-fixing to defend himself in a related criminal case, arguing the request would create an unfair advantage since the court previously rejected a similar ask from the government.
-
May 23, 2023
DOJ, Drug Buyers Rip Teva's Criminal Probe Doc Bid In MDL
The government and drug buyers fired back in separate filings in Pennsylvania federal court Tuesday against Teva's bid to use material from a criminal investigation into alleged generic drug price-fixing to defend itself in parallel civil multidistrict litigation over similar allegations, arguing it would undermine prosecutions and create a procedural "mess."
-
March 20, 2023
DOJ Defends Ask For Docs From Drug Price-Fixing MDL
The U.S. Department of Justice defended its bid for discovery materials from multidistrict litigation over generic drug price-fixing claims for use in the government's related criminal prosecutions, rejecting the pharmaceutical companies' claims that the DOJ wanted "unfettered access."